These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 16253574)

  • 1. Receptor-ligand binding assays: technologies and applications.
    de Jong LA; Uges DR; Franke JP; Bischoff R
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Dec; 829(1-2):1-25. PubMed ID: 16253574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ratiometric Ca+2 measurement in human recombinant muscarinic receptor subtypes using the Flexstation scanning fluorometer.
    Gupta S; Singh RK; Nanda K; Chatterjee M; Tiwari A; Sundaram S; Gupta D; Chugh A; Dastidar S; Ray A
    J Recept Signal Transduct Res; 2009; 29(2):100-6. PubMed ID: 19288301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a multiplex non-radioactive receptor assay: the benzodiazepine receptor, the serotonin transporter and the beta-adrenergic receptor.
    de Jong LA; Jeronimus-Stratingh CM; Cremers TI
    Rapid Commun Mass Spectrom; 2007; 21(4):567-72. PubMed ID: 17245793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lanthanide-based time-resolved fluorescence of in cyto ligand-receptor interactions.
    Handl HL; Vagner J; Yamamura HI; Hruby VJ; Gillies RJ
    Anal Biochem; 2004 Jul; 330(2):242-50. PubMed ID: 15203329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expression of recombinant human LOX-1 and identifying its mimic ligands by fluorescence polarization-based high throughput screening.
    Zhang T; Huang Z; Dai Y; Chen X; Zhu P; Du G
    J Biotechnol; 2006 Oct; 125(4):492-502. PubMed ID: 16735073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward efficient drug screening by homogeneous assays based on the development of new fluorescent vasopressin and oxytocin receptor ligands.
    Albizu L; Teppaz G; Seyer R; Bazin H; Ansanay H; Manning M; Mouillac B; Durroux T
    J Med Chem; 2007 Oct; 50(20):4976-85. PubMed ID: 17850055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A rapid, homogeneous, fluorescence polarization binding assay for peroxisome proliferator-activated receptors alpha and gamma using a fluorescein-tagged dual PPARalpha/gamma activator.
    Seethala R; Golla R; Ma Z; Zhang H; O'Malley K; Lippy J; Cheng L; Mookhtiar K; Farrelly D; Zhang L; Hariharan N; Cheng PT
    Anal Biochem; 2007 Apr; 363(2):263-74. PubMed ID: 17335769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of the MultiScreen system to cytokine radioreceptor assays.
    Slack J; Sims JE; Pitt AM; Dower SK
    Biotechniques; 1989; 7(10):1132-8. PubMed ID: 2534274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell imaging assays for G protein-coupled receptor internalization: application to high-throughput screening.
    Lee S; Howell B; Kunapuli P
    Methods Enzymol; 2006; 414():79-98. PubMed ID: 17110188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. G protein-coupled receptor internalization assays in the high-content screening format.
    Haasen D; Schnapp A; Valler MJ; Heilker R
    Methods Enzymol; 2006; 414():121-39. PubMed ID: 17110190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assays for membrane tyrosine kinase receptors: methods for high-throughput screening and utility for diagnostics.
    Minor LK
    Expert Rev Mol Diagn; 2005 Jul; 5(4):561-71. PubMed ID: 16013974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The BRET technology and its application to screening assays.
    Bacart J; Corbel C; Jockers R; Bach S; Couturier C
    Biotechnol J; 2008 Mar; 3(3):311-24. PubMed ID: 18228541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational chemistry approaches to drug discovery in signal transduction.
    Fischer PM
    Biotechnol J; 2008 Apr; 3(4):452-70. PubMed ID: 18412174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in membrane receptor screening and analysis.
    Cooper MA
    J Mol Recognit; 2004; 17(4):286-315. PubMed ID: 15227637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lanthanide-based luminescent assays for ligand-receptor interactions.
    Handl HL; Gillies RJ
    Life Sci; 2005 Jun; 77(4):361-71. PubMed ID: 15894006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Identification of ligands for human LOX-1 through fluorescence polarization-based high throughput screening].
    Zhang TT; Huang ZT; Dai Y; Liu AL; Zhu P; Du GH
    Yao Xue Xue Bao; 2005 Sep; 40(9):792-5. PubMed ID: 16342678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A simple theoretical model for fluorescence polarization binding assay development.
    Nosjean O; Souchaud S; Deniau C; Geneste O; Cauquil N; Boutin JA
    J Biomol Screen; 2006 Dec; 11(8):949-58. PubMed ID: 17092915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NMR fragment screening: Advantages and applications.
    Schade M
    IDrugs; 2006 Feb; 9(2):110-3. PubMed ID: 16523400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular and cellular approaches for the detection of protein-protein interactions: latest techniques and current limitations.
    Lalonde S; Ehrhardt DW; Loqué D; Chen J; Rhee SY; Frommer WB
    Plant J; 2008 Feb; 53(4):610-35. PubMed ID: 18269572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional analysis of cell-free-produced human endothelin B receptor reveals transmembrane segment 1 as an essential area for ET-1 binding and homodimer formation.
    Klammt C; Srivastava A; Eifler N; Junge F; Beyermann M; Schwarz D; Michel H; Doetsch V; Bernhard F
    FEBS J; 2007 Jul; 274(13):3257-69. PubMed ID: 17535295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.